戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 acillus rhamnosus ATCC 7469 (formerly called Lactobacillus casei).
2 a pathogenic Listeria (Lm) on the surface of Lactobacillus casei.
3 ptococcus mutans, Enterococcus faecalis, and Lactobacillus casei.
4 vity was noted with Streptococcus mutans and Lactobacillus casei.
5 g homolactic fermentation in the presence of Lactobacillus casei.
6  of identity to each other and to the FLP of Lactobacillus casei.
7                            The effect of the Lactobacillus casei 01 and inulin addition on sheep milk
8 ological (lactic acid bacteria and probiotic Lactobacillus casei 01 counts and survival under gastroi
9 cted by insertional mutagenesis of dltD from Lactobacillus casei 102S.
10 coccus sanguinus, Lactobacillus acidophilus, Lactobacillus casei, Actinomyces naeslundii genospecies
11 at the general acid/base residue E274 of the Lactobacillus casei alpha1,6-fucosidase, including E274A
12 imidines versus dihydrofolate reductase from Lactobacillus casei and chicken liver.
13 ore inhibitory than LY231514 against TS from Lactobacillus casei and Escherichia coli.
14 butanol were identified as relevant VOCs for Lactobacillus casei and Lactobacillus paracasei subsp.
15 butanol were identified as relevant VOCs for Lactobacillus casei and Lactobacillus paracasei subsp. p
16  (DltA) in Lactobacillus rhamnosus (formerly Lactobacillus casei) and Bacillus subtilis.
17  Toxoplasma gondii, Mycobacterium avium, and Lactobacillus casei) and showed good to modest activity
18 d 58% with Escherichia coli, 35 and 56% with Lactobacillus casei, and 23 and 40% with Thermotoga mari
19  Pneumocystis carinii, T. gondii, rat liver, Lactobacillus casei, and Escherichia coli, and selected
20 d tyrosine (Y94 in Escherichia coli, Y146 in Lactobacillus casei, and Y135 in humans) was assumed to
21 ange rates measured on assigned signals from Lactobacillus casei apo-DHFR and its binary and ternary
22                                  We selected Lactobacillus casei as a model microorganism to proceed
23 ur GCMS method correlate (R = 0.98) with the Lactobacillus casei assay for whole blood folate.
24 d blood cell folate values obtained with the Lactobacillus casei assay have formed the basis for curr
25         Inspection of the genome sequence of Lactobacillus casei ATCC 334 revealed two operons that m
26 rains (Lactobacillus helveticus DPC 4571 and Lactobacillus casei ATCC 334) directly or after sonicati
27 ures of the acid tolerance response (ATR) in Lactobacillus casei ATCC 334.
28      The effect of the amount of immobilized Lactobacillus casei ATCC 393 on wheat grains on the gene
29 f the probiotic culture (free or immobilized Lactobacillus casei ATCC 393 on wheat grains) and the ri
30 of Lactobacillus acidophilus (ATCC(R) 4356), Lactobacillus casei (ATCC(R) 393) and Lactobacillus para
31 2)) and significantly promoted the growth of Lactobacillus casei BCC36987.
32 ies, Lactobacillus paracasei CNCM I-3689 and Lactobacillus casei BL23, on L. monocytogenes and orally
33 tified in prophages present in the genome of Lactobacillus casei BL23.
34 lation (Lactobacillus plantarum CECT 220 and Lactobacillus casei CECT 475) in order to evaluate the a
35 mouse model of KD that involves injection of Lactobacillus casei cell wall extract (LCWE), we investi
36                           After injection of Lactobacillus casei cell-wall extract (LCCWE), mice deve
37 lass switch, the microRNA (miR)-23b(-/-) and Lactobacillus casei (Chinese Industrial Microbial Cultur
38 t on the enzyme dihydrofolate reductase from Lactobacillus casei complexed with methotrexate, NADPH a
39  aim of the study is to evaluate the role of Lactobacillus casei DG (LC-DG) and its postbiotic (PB) i
40 nsional solution structure of the complex of Lactobacillus casei dihydrofolate reductase (18.3 kDa, 1
41 been made for the eight arginine residues in Lactobacillus casei dihydrofolate reductase in its binar
42 protective effects of heat-killed LAB strain Lactobacillus casei DK128 (DK128) on influenza viruses.
43 onstrating that tryptophan 82 mutants of the Lactobacillus casei enzyme produced 5-(2-hydroxyethyl)th
44 eet 5, based on the crystal structure of the Lactobacillus casei enzyme.
45 alogues were also evaluated as inhibitors of Lactobacillus casei, Escherichia coli, and rat and rh th
46  The compounds were evaluated against human, Lactobacillus casei, Escherichia coli, Streptococcus fae
47 te based on the ternary crystal structure of Lactobacillus casei FPGS.
48 proteins (FolT, ThiT) were identified in the Lactobacillus casei genome, expressed in Lactococcus lac
49 bacillus acidophilus, Lactobacillus reuteri, Lactobacillus casei GG, and Bifidobacterium animalis) to
50 bacillus acidophilus, Lactobacillus reuteri, Lactobacillus casei GG, or Bifidobacterium animalis) in
51 UMP (in contrast, the N229(177)V mutation in Lactobacillus casei has minimal effect on activity).
52 s very similar to the C-terminal fragment of Lactobacillus casei HPrK/P and the C-terminal domain of
53 ixture of the three probiotic strains (2:1:1 Lactobacillus casei IMVB-7280, Bifidobacterium animalis
54               Using the structure of TS from Lactobacillus casei in complex with the nonsubstrate ana
55 al activity against Streptococcus mutans and Lactobacillus casei (in both planktonic growth and biofi
56 lture of Candida albicans, Escherichia coli, Lactobacillus casei, L. reuteri, L. acidophilus, a Bifid
57               Three probiotic strains namely Lactobacillus casei, Lactobacillus brevis and Lactobacil
58 nd dysbiosis, featured by decreased level of Lactobacillus casei, Lactobacillus johnsonii and increas
59                                              Lactobacillus casei, Lactobacillus johnsonii, and Lactob
60                 According to the literature, Lactobacillus casei, Lactobacillus reuteri, Lactobacillu
61  identified as being clinically significant: Lactobacillus casei, Lactobacillus rhamnosus, and Lactob
62 omposed of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus
63 c (Bio-K+: Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus
64 ecium (sf) DHFR, Escherichia coli (ec) DHFR, Lactobacillus casei (lc) DHFR and tgDHFR with hDHFR as t
65                  The analogues 2-4 inhibited Lactobacillus casei (lc) TS and recombinant human (h) TS
66 ) from human (hs), Escherichia coli (ec) and Lactobacillus casei (lc) were elucidated and compared us
67 jection of a cell wall extract isolated from Lactobacillus casei (LCCWE) into mice causes a focal cor
68                           bulgaricus-151 and Lactobacillus casei-LcY were the most advantageous with
69 fect of inoculation with a probiotic strain, Lactobacillus casei LOCK 0900, on selected parameters re
70  vitamins and minerals or a probiotic agent (Lactobacillus casei) may impact recurrence rates.
71 strate for producing a probiotic beverage by Lactobacillus casei NRRL B442.
72 ecific activity 2-3-fold higher than TS from Lactobacillus casei or Escherichia coli.
73                          Chickens were given Lactobacillus casei over-expressing myosin-cross-reactiv
74 c acid bacteria (Lactobacillus plantarum and Lactobacillus casei) over 72 h.
75                                              Lactobacillus casei produces an alpha-fucosidase, called
76 ane-associated D-alanyl-lipoteichoic acid in Lactobacillus casei requires the 56-kDa D-alanine-D-alan
77 1 +/- 0.05 for Lactobacillus acidophilus and Lactobacillus casei, respectively.
78 ent was determined by microbiological assay (Lactobacillus casei rhamnosus) and tri-enzyme (protease,
79     We assessed whether an intervention with Lactobacillus casei Shirota (LcS) in elderly nursing hom
80 CI: 0.7, 2.3 bowel movements/wk) but not for Lactobacillus casei Shirota (WMD: -0.2 bowel movements/w
81 actococcus latics subsp. lactis strain X and Lactobacillus casei strain B extracts had an MIC of 10mg
82 althy oral biofilms (Actinomyces naeslundii, Lactobacillus casei, Streptococcus mitis, Veillonella pa
83 12,130, Lactobacillus lactis BCMC(R) 12,451, Lactobacillus casei subsp BCMC(R) 12,313, Bifidobacteriu
84 ependent growth of chloramphenicol-resistant Lactobacillus casei subspecies rhamnosus (NCIMB 10463).
85  and our results agree well with those using Lactobacillus casei, the current gold standard reference
86 ctures of ternary complexes of the wild-type Lactobacillus casei thymidylate synthase enzyme.
87 -1 was augmented after low-dose probiotic or Lactobacillus casei treatment, but B7RP-1 showed increas
88              Similar to previously described Lactobacillus casei TS inhibition studies with sulfhydry
89 ta, a Chilean native berry, impregnated with Lactobacillus casei var. rhamnosus and dehydrated by dif
90 g a murine model of KD in which injection of Lactobacillus casei wall extract (LCWE) induces coronary
91                  In the bacterial synthesis, Lactobacillus casei was grown in the presence of 1 ng/ml
92 mulate T cells and elicit cytokines and used Lactobacillus casei, which often predominates in deep ca